Literature DB >> 3890660

Acute pancreatitis.

M C Geokas, H A Baltaxe, P A Banks, J Silva, C F Frey.   

Abstract

The exocrine pancreas secretes into the gut on demand more than 20 proteins that are indispensable for digestion. In-vivo autodigestion is prevented by an array of natural safeguards. In acute pancreatitis, inappropriate intrapancreatic activation and release of pancreatic hydrolases occur, but the pathogenetic mechanism of autodigestion is unclear. The release of proteases, lipase and colipase, phospholipase A, vasoactive peptides, and other agents probably accounts for the edema, tissue destruction, fat necrosis, metabolic abnormalities, and complications. Ethyl alcohol abuse, gallstones, trauma, and other common and rare conditions can induce pancreatitis. The patient's outcome can be predicted by certain prognostic signs. Ultrasonography and computerized tomography are invaluable diagnostic tools and magnetic resonance imaging appears promising. Hemodynamic monitoring, intensive care with colloid and crystalloid infusions, correction of electrolyte abnormalities, judicious use of antibiotics, peritoneal lavage, drainage of pancreatic exudation fluids, and surgical intervention require a team approach, especially in patients with multiple complications. Additional research is needed into the pathogenetic mechanism of autodigestion and the design of specific therapies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890660     DOI: 10.7326/0003-4819-103-1-86

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  The pharmacological properties of the novel peptide BPC 157 (PL-10).

Authors:  P Sikiric
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

2.  Sequential abdominal reexploration with the zipper technique.

Authors:  M A Cuesta; M Doblas; L Castañeda; E Bengoechea
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

3.  Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.

Authors:  P Sikirić; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; L Jurina; P Konjevoda; M Hanzevacki; D Ljubanović; J Separović; M Gjurasin; M Bratulić; B Artuković; N Jelovac; G Buljat
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

4.  Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats.

Authors:  W Kimura; J Mössner
Journal:  Int J Pancreatol       Date:  1996-12

5.  Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.

Authors:  G R Birchfield; J H Ward; B G Redman; L Flaherty; W E Samlowski
Journal:  West J Med       Date:  1990-06

6.  Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats.

Authors:  W Kimura; K Okubo; I Han; S Kanai; A Matsushita; T Muto; K Miyasaka
Journal:  Int J Pancreatol       Date:  1996-04

7.  Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis.

Authors:  A H Lundberg; K Fukatsu; L Gaber; S Callicutt; M Kotb; H Wilcox; K Kudsk; A O Gaber
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

8.  Nonesterified fatty acids in acute cerulein-induced pancreatitis in the rat. Are they really deleterious in vivo?

Authors:  F Paye; J Chariot; G Molas; J Benessiano; C Rozé
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

9.  Biochemical studies in peritoneal fluid from patients with acute pancreatitis. Relationship to etiology.

Authors:  M A Dubick; A D Mayer; A P Majumdar; G Mar; M J McMahon; M C Geokas
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

10.  Protective effect of antithrombin III in acute experimental pancreatitis in rats.

Authors:  W K Bleeker; J Agterberg; G Rigter; C E Hack; J V Gool
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.